ICL, a global manufacturer of products based on specialty minerals announced that its ICL Industrial Products segment has initiated start-up activities of its manufacturing facility in Israel for the production of FR-122P, ICL IP’s new polymeric flame retardant (FR).
ICL IP, one of ICL’s three operating segments, manufactures and markets a broad range of industrial chemicals based on bromine, magnesia, chlorine and salts. ICL-IP’s bromine-based products are life-saving components that reduce the mercury emissions of coal-burning power stations, enhance the safety of deep-water oil and gas drilling operations, and minimize the fire hazard associated with consumer electronics, automobiles, furniture, insulation, and other widely-used products. In addition, the pharmaceutical industry uses bromine as an intermediary in the manufacture of drugs for the treatment of cancer, epilepsy, heart disease and other life-threatening conditions.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
The recently completed ICL IP’s FR-122P production facility in Israel is currently progressing through the startup stage following the successful feed of raw materials into the plant. The facility, ICL says, will eventually have a production capacity of 10, 000MT. It joins ICL IP’s other facility for the manufacture of FR-122P which is located in the Netherlands and which already produces and markets commercial quantities of FR-122P. The European facility has the potential to expand further to increase capacity significantly in a relatively short period of time in order to meet growing market demand.
Its FR-122P product replaces its previous flame retardant, HBCD, currently the standard used in EPS/XPS insulation foams, and which, according to European Union regulations, will be phased out of the market by August 2015. The product derives from a licensing agreement ICL IP entered into with Dow Global Technologies LLC for the manufacture of FR-122P.
Mrs. Anat Tal, Deputy CEO of ICL IP, said, “We are delighted to establish our second FR-122P production facility in order to serve customers in the EPS and XPS industries. We trust that our increased production capacity and the availability of our product will encourage and enable our customers to transition from their use of HCBD within the period mandated by the EU. ICL IP has invested heavily to bring this sustainable polymeric product to market so that our customers can produce their downstream products knowing that they meet the latest fire safety standards. We remain committed to leading our industry in offering innovative, environmentally-friendly fire safety products.”
